Sign up to save your podcasts
Or
Share The FirstTake Podcast – Where next for gene editing?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The FirstTake Podcast – Where next for gene editing?
On this week’s episode FirstWord Pharma PLUS editors Virginia Li, Michael Flanagan and Simon King discuss key developments in the field of gene editing, the approval of Janssen and Legend Biotech’s Carvykti for multiple myeloma and whether interchangeability status will have a meaningful impact on future US market for Humira biosimilars.
View all episodes
By FirstWord PharmaOn this week’s episode FirstWord Pharma PLUS editors Virginia Li, Michael Flanagan and Simon King discuss key developments in the field of gene editing, the approval of Janssen and Legend Biotech’s Carvykti for multiple myeloma and whether interchangeability status will have a meaningful impact on future US market for Humira biosimilars.